Moleculin CEO discusses early MIRACLE trial data in investor segment
Go back to Moleculin CEO discusses early MIRACLE trial data in investor segment| METABASIS THERAPEUT (NASDAQ: MBRX) | Delayed: 2.08 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.08 | 52 Week High | $9.58 | |||
| Open | $2.08 | 52 Week Low | $2.34 | |||
| Day High | $2.08 | P/E | N/A | |||
| Day Low | $2.08 | EPS | $-0.34 | |||
| Volume | 15 | |||||
